Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
BIIB
IDXX
Add up to 3 more stocks
BIIB
Biogen Inc.
+1.99%
$214.93+4.20Delayed quote: Sep 10, 2026, 10:30 AM EDT
Market Cap
$31.76B
52W Range
$135.39 - $225.80
IDXX
IDEXX Laboratories, Inc.
-0.49%
$512.65-2.50Delayed quote: Sep 10, 2026, 10:30 AM EDT
Market Cap
$40.44B
52W Range
$511.25 - $769.98
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 38.04 | 36.31 |
| Forward P/E | 17.21 | 34.71 |
| P/B Ratio | 1.68 | 25.08 |
| P/S Ratio | 3.19 | 8.88 |
| P/FCF Ratio | 11.78 | 32.34 |
| EV/EBITDA | N/A | 25.63 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 67.7% | 62.5% |
| Operating Margin | 12.8% | 32.0% |
| Net Margin | 8.4% | 25.0% |
| ROE | 4.4% | 70.7% |
| ROA | 2.6% | 33.1% |
| ROIC | 4.3% | 41.3% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 1.87 | 1.17 |
| Quick Ratio | 1.26 | 0.87 |
| Debt/Equity | 0.44 | 0.68 |
| Interest Coverage | 7.63 | 35.54 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.